STOCK TITAN

PETVIVO HOLDINGS (PETV) Stock News, Feb-Jun 2024

PETV OTC

PetVivo Holdings develops and commercializes veterinary medical devices and biomedical therapeutics for companion animals and equines through PetVivo Animal Health and PetVivo AI. Its recurring company updates center on Spryng with OsteoCushion Technology, a veterinarian-administered intra-articular injection for joint-related conditions including lameness and osteoarthritis, and PrecisePRP, an off-the-shelf platelet-rich plasma product for veterinary use.

News also covers regulatory acknowledgements, product availability, licensing and commercialization activity, PetVivo.ai and AgenticPet AI technology, fiscal results, conference presentations, and capital-market communications. The company describes a strategy of applying human therapies to animal health and protects its biomaterials, products, production processes and methods of use through patents and trade secrets.

Rhea-AI Summary

PetVivo will hold a conference call on June 28, 2024, at 5:00 p.m. ET to discuss fiscal Q4 and annual results ended March 31, 2024. The financial results will be released prior to the call. Management will present and answer questions. Dial-in and webcast replay options are available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.11%
Tags
conferences earnings
-
Rhea-AI Summary

PetVivo Holdings has appointed Bryan Monninger as their new VP of Sales. Monninger brings over 20 years of experience in sales and marketing, including senior roles at NOVUS, Colgate-Palmolive, Lintbells, and ConAgra. He will lead PetVivo's sales and distribution teams to expand the market adoption of their animal osteoarthritis product, Spryng™ with OsteoCushion™ Technology. Monninger's extensive background includes successful market entries, strategic planning, and sales growth acceleration. CEO John Lai expects Monninger's expertise to drive PetVivo's growth and expand their market reach both domestically and internationally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
Rhea-AI Summary

PetVivo Holdings announced that April Boyce has joined as Vice President of Marketing. Boyce, with over 20 years of experience in consumer-packaged goods (CPG) marketing, sales, and strategic partnerships, has held significant roles at Procter & Gamble and Clorox. At Clorox, she led the shopper marketing division and formed strategic partnerships with companies like Burt's Bees, Coca-Cola, and Tyson Foods. Her most recent role was Chief Commercial Officer at pet tech start-up, Link. Boyce aims to enhance awareness and understanding of PetVivo's veterinary medical device, Spryng with OsteoCushion Technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.56%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.94%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.94%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.01%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.65%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of PETVIVO HOLDINGS (PETV)?

PETVIVO HOLDINGS (PETV) last closed at $0.75.

What is the market cap of PETVIVO HOLDINGS (PETV)?

The market cap of PETVIVO HOLDINGS (PETV) is approximately $28.5M.